DGX (DGX) Stock Analysis

DGX (DGX) is a publicly traded company in the HEALTHCARE sector. It trades at $193.18, carries a market capitalization of $21.28B, a price-to-earnings ratio of 21.26, a dividend yield of 0.02%. This page summarizes the public market data, fundamentals, and frequently asked questions for DGX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NYSE

Key Metrics

Market Sentiment

DGX currently has a Neutral sentiment score of -0.05.

About DGX

Quest Diagnostics Incorporated (DGX) is a premier American clinical laboratory and a recognized leader in the healthcare sector, ranked among the Fortune 500 companies. The company operates across the United States as well as in Puerto Rico, Mexico, and Brazil, providing a wide array of diagnostic testing services that support healthcare providers and enhance individual health management. Through its strategic partnerships with hospitals and clinics globally, Quest diagnostics expands its ser...

GNG Research Analysis

GNG Research scores DGX (DGX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DGX.

Frequently Asked Questions

What is DGX's current dividend yield?

DGX (DGX) has a current dividend yield of 0.02%.

Does DGX pay dividends?

Yes, DGX pays dividends with a current yield of 0.02%.

What is DGX's P/E ratio?

DGX has a price-to-earnings (P/E) ratio of 21.26.

What is DGX's market cap?

DGX (DGX) has a market capitalization of $21.28B with a current stock price of $193.18.